Is it okay not to use chemo after a immersion of breast cancer?

Irritated breast cancer is a breast cancer in which a cancer cell has broken through a breast catheter or the base membrane of a leaf and invaded the normal tissue around it. Surgery is one of the main means of treating impregnated breast cancer, but the need for post-operative chemotherapy needs to be determined on the basis of the patient ‘ s specific circumstances and the characteristics of the tumor.The role of chemotherapy.chemotherapy is a treatment that uses drugs to kill or stop the growth of cancer cells. In the treatment of immersed breast cancer, chemotherapy can:Reducing the risk of relapse: For certain types of breast cancer, chemotherapy can significantly reduce the likelihood of post-operative recurrence.Control of remote transfer: chemotherapy helps to eliminate cancer cells that may have spread to other parts of the body.Improved survival: For high-risk patients, chemotherapy increases the chances of long-term survival.It’s a decision about chemotherapy.The following factors are taken into account by doctors in the conduct of chemotherapy:The size and grade of the tumor: The larger the tumor, the higher the grade, the greater the need for chemotherapy.lymph nodes: chemotherapy may be more necessary if cancer cells have spread to lymph nodes.Hormonal receptor state: tumours that are hormonal receptor positive may react well to endocrine treatment, but chemotherapy may still be necessary.HeR2 status: HeR2 positive breast cancer patients usually require chemotherapy and may be treated with an additional target for HeR2.Overall health status of the patient: age, complications, preferences, etc.Molecular subtypes: Different subtypes of breast cancer respond differently to chemotherapy.No chemotherapy.In some cases, the patient may not need chemotherapy:Early breast cancer: Some early breast cancers (e.g., small tumours, lymphoma, hormone-positive) may not require chemotherapy.Low-risk tumours: Some low-risk tumours, such as lower-grade immersion catheter cancer, may not require chemotherapy.Older patients: The potential side effects of chemotherapy may outweigh the benefits for older patients.Patient preference: After being fully informed of the advantages and disadvantages of chemotherapy, the patient may choose not to accept chemotherapy.Risk of non-chemical treatmentChoosing not to undergo chemotherapy may pose the following risks:Increased risk of recurrence: Without chemotherapy, the risk of cancer recurrence may increase.Reduced survival rate: For some patients, chemotherapy can increase survival, and the absence of chemotherapy may affect this outcome.Possibilities for remote transfer: chemotherapy helps to control potential remote transfer, and failure to undergo chemotherapy may increase the risk of diversion.Alternative treatmentIf the patient is not fit for chemotherapy, the doctor may consider the following alternatives:Endocrine treatment: For hormonal receptor-positive breast cancer, endocrinological treatment inhibits the contribution of hormone to cancer cells.Target treatment: In the case of Sher2-positive breast cancer, the Target Treatment can treat Her2 protein.Demobilisation: The demobilisation can be used for the local control of tumours, especially after surgery.ConclusionsIt is a complex decision whether or not to undergo chemotherapy after immersion of breast cancer, which needs to be made on the basis of the patient ‘ s specific condition, the character of the tumor and the patient ‘ s personal preference. Doctors usually provide individualized treatment advice based on updated clinical guidelines and research.If the patient considers not to undergo chemotherapy, there should be adequate communication with the doctor regarding the possible consequences of not chemotherapy and alternative treatment options. In some cases, non-chemical treatment is feasible, especially for low-risk patients. For many patients, however, chemotherapy remains an important means of reducing the risk of relapse and improving survival rates.Ultimately, patients should make the most appropriate treatment decisions with the medical team, based on a full understanding of all available information.